FDA MedWatch - June 2014 safety labeling changes includes 52 products with revisions to prescribing information

The MedWatch June 2014 Safety Labeling Changes posting includes 37 products with safety labeling changes to the following sections: BOXED WARNINGS, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS and PATIENT PACKAGE INSERT.

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

The "Summary Page" provides a listing of product names and safety labeling sections revised:

http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm402776.htm

The following drugs had modifications to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS and PRECAUTIONS sections:

Alsuma (sumatriptan)
Androderm (testosterone)
AndroGel (testosterone) gel
Avalide (irbesartan and hydrochlorothiazide)
Aveed (testosterone undecanoate)
Axiron (testosterone)
Benicar (olmesartan medoxomil)
Benicar HCT (olmesartan medoxomil-hydrochlorothiazide)
Caverject (alprostadil for injection)       
Caverject Impulse Dual Chamber System (alprostadil for injection)
Cerebyx (Fosphenytoin Sodium Injection)
Cleocin Phosphate (Clindamycin injection, USP) and (clindamycin injection in 5 percent dextrose)
Cleocin HCL (clindamycin hydrochloride)
Complera (emtricitabine, rilpivirine, tenofovir disoproxil fumarate)
Comtan (entacapone)     
Delatestryl (testosterone enanthate)  
Ella (ulipristal acetate)
Fortesta (testosterone) gel
Gazyva (obinutuzumab)
Herceptin (trastuzumab)  
Hycamtin (topotecan)
Jetrea (ocriplasmin)
Lupron Depot (leuprolide acetate)   
Nutropin AQ (somatropin [rDNA origin])   
Prolia (denosumab)
Ravicti (glycerol phenylbutyrate)
Saizen (somatropin [rDNA origin])
Serostim (somatropin [rDNA origin] for injection)
Sporanox (itraconazole)
Striant (testosterone)
Sutent (sunitinib malate)
Symlin (pramlintide acetate)
Testim (testosterone)
Testosterone gel
Tev-Tropin (somatropin [rDNA origin])
Thalomid (thalidomide)
Tribenzor (olmesartan medoxomil, amlodipine, hydrochlorothiazide)  
Trileptal (oxcarbazepine)
Votrient (pazopanib)  
Xgeva (denosumab)  
Zestril (lisinopril)

 

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report